JP2016116523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016116523A5
JP2016116523A5 JP2016000288A JP2016000288A JP2016116523A5 JP 2016116523 A5 JP2016116523 A5 JP 2016116523A5 JP 2016000288 A JP2016000288 A JP 2016000288A JP 2016000288 A JP2016000288 A JP 2016000288A JP 2016116523 A5 JP2016116523 A5 JP 2016116523A5
Authority
JP
Japan
Prior art keywords
adipose tissue
derived stromal
stromal stem
stem cells
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016000288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016116523A (ja
JP6545624B2 (ja
Filing date
Publication date
Priority claimed from US11/167,061 external-priority patent/US20060045872A1/en
Application filed filed Critical
Publication of JP2016116523A publication Critical patent/JP2016116523A/ja
Publication of JP2016116523A5 publication Critical patent/JP2016116523A5/ja
Application granted granted Critical
Publication of JP6545624B2 publication Critical patent/JP6545624B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2016000288A 2005-06-24 2016-01-04 瘻の治療における脂肪組織由来間質幹細胞の使用 Expired - Fee Related JP6545624B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/167,061 2005-06-24
US11/167,061 US20060045872A1 (en) 2004-08-25 2005-06-24 Use of adipose tissue-derived stromal stem cells in treating fistula

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013218552A Division JP6289858B2 (ja) 2005-06-24 2013-10-21 瘻の治療における脂肪組織由来間質幹細胞の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019018275A Division JP6812475B2 (ja) 2005-06-24 2019-02-04 瘻の治療における脂肪組織由来間質幹細胞の使用

Publications (3)

Publication Number Publication Date
JP2016116523A JP2016116523A (ja) 2016-06-30
JP2016116523A5 true JP2016116523A5 (enExample) 2016-10-20
JP6545624B2 JP6545624B2 (ja) 2019-07-17

Family

ID=37116048

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2008517346A Pending JP2008546397A (ja) 2005-06-24 2006-05-16 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2013218552A Expired - Lifetime JP6289858B2 (ja) 2005-06-24 2013-10-21 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2016000288A Expired - Fee Related JP6545624B2 (ja) 2005-06-24 2016-01-04 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2019018275A Expired - Lifetime JP6812475B2 (ja) 2005-06-24 2019-02-04 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2020088068A Expired - Lifetime JP7027484B2 (ja) 2005-06-24 2020-05-20 瘻の治療における脂肪組織由来間質幹細胞の使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008517346A Pending JP2008546397A (ja) 2005-06-24 2006-05-16 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2013218552A Expired - Lifetime JP6289858B2 (ja) 2005-06-24 2013-10-21 瘻の治療における脂肪組織由来間質幹細胞の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019018275A Expired - Lifetime JP6812475B2 (ja) 2005-06-24 2019-02-04 瘻の治療における脂肪組織由来間質幹細胞の使用
JP2020088068A Expired - Lifetime JP7027484B2 (ja) 2005-06-24 2020-05-20 瘻の治療における脂肪組織由来間質幹細胞の使用

Country Status (23)

Country Link
US (10) US20060045872A1 (enExample)
EP (7) EP1899458A2 (enExample)
JP (5) JP2008546397A (enExample)
KR (1) KR20080036588A (enExample)
CN (2) CN101263224A (enExample)
AU (1) AU2006261383B2 (enExample)
BR (1) BRPI0613811B8 (enExample)
CA (1) CA2613457C (enExample)
CY (3) CY1116764T1 (enExample)
DK (4) DK3176254T3 (enExample)
ES (6) ES2696537T3 (enExample)
HU (3) HUE025338T2 (enExample)
IL (1) IL188378A (enExample)
LT (3) LT3176255T (enExample)
LU (1) LUC00085I2 (enExample)
NL (1) NL300953I2 (enExample)
NZ (2) NZ594848A (enExample)
PL (3) PL3176255T3 (enExample)
PT (3) PT2292737E (enExample)
RU (3) RU2435846C2 (enExample)
SG (1) SG166770A1 (enExample)
SI (3) SI2292737T2 (enExample)
WO (1) WO2006136244A2 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US7803787B2 (en) * 2002-10-16 2010-09-28 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage by transmucosal administration
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
JP2008541238A (ja) 2005-05-05 2008-11-20 アーキペラゴ ホールディングス インコーポレイテッド 値段が付けられていない注文のオークション及び転送
US20070027543A1 (en) * 2005-08-01 2007-02-01 Gimble Jeffrey M Use of adipose tissue-derived stromal cells in spinal fusion
CA2623353C (en) 2005-09-23 2017-02-21 Cellerix, S.L. Cell populations having immunoregulatory activity, method for isolation and uses
US20100322906A1 (en) * 2005-10-05 2010-12-23 Osaka University Method for Obtaining Pancreatic Endocrine Cells From Adipose Tissue-Origin Cells
AU2006320507B2 (en) * 2005-12-02 2012-11-01 Cook Medical Technologies Llc Devices, systems, and methods for occluding a defect
US20090209031A1 (en) * 2006-01-26 2009-08-20 Tyco Healthcare Group Lp Medical device package
WO2007089798A2 (en) * 2006-01-30 2007-08-09 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
US20070224173A1 (en) * 2006-03-21 2007-09-27 Koullick Edouard A Nonexpansion Protocol for Autologous Cell-Based Therapies
WO2008024996A2 (en) * 2006-08-24 2008-02-28 Johnstone Brian H Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith
JP2010505849A (ja) * 2006-10-06 2010-02-25 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病性創傷治癒に有用な方法および組成物
KR20080103637A (ko) * 2007-05-25 2008-11-28 주식회사 알앤엘바이오 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
AU2014227541B2 (en) * 2007-09-19 2015-10-01 Pluristem Ltd. Methods of Treating Inflammatory Colon Diseases
EP2303293A1 (en) * 2008-05-27 2011-04-06 Pluristem Ltd. Methods of treating inflammatory colon diseases
WO2009152084A2 (en) * 2008-06-11 2009-12-17 Cell4Vet Llc Adipose tissue-derived stem cells for veterinary use
JP5763535B2 (ja) * 2008-06-24 2015-08-12 バイオアクティブ サージカル インコーポレイテッド 幹細胞または他の生理活性材料が組み込まれた外科手術用縫合糸
US20100098739A1 (en) * 2008-10-20 2010-04-22 University Of Virginia Patent Foundation Compositions and methods for modular soft tissue repair
US20100112696A1 (en) * 2008-11-03 2010-05-06 Baxter International Inc. Apparatus And Methods For Processing Tissue To Release Cells
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
ES2479621T3 (es) * 2009-04-28 2014-07-24 Anterogen Co., Ltd. Composición de células madre estromales derivadas de tejido adiposo autólogo y alogénico destinada al tratamiento de fístulas
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9669200B2 (en) 2010-08-06 2017-06-06 Boston Scientific Scimed, Inc. Systems and methods for the treatment of pelvic disorders including magnetic particulates
EP4663241A3 (en) 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
US9180172B2 (en) 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
US8979797B2 (en) 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
WO2012095743A2 (en) 2011-01-12 2012-07-19 Cellerix Sa Methods and compositions for use in intralymphatic cellular therapies
WO2012123401A1 (en) 2011-03-11 2012-09-20 Tigenix, S.A. Cell populations having immunoregulatory activity, method for isolation and uses
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
CL2011001904A1 (es) * 2011-08-08 2012-03-09 Univ Pontificia Catolica Chile Formulacion farmaceutica que comprende celulas madres mesenquimales vivas suspendidas en un vehiculo farmaceuticamente aceptable, sistema de aplicacion topica en aerosol que las comprende; y su uso para tratar heridas.
US20130072903A1 (en) * 2011-09-20 2013-03-21 John Chapman Adipose Tissue Graft for Wound Healing
GB201202319D0 (en) * 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
US20140024011A1 (en) * 2012-07-23 2014-01-23 AdiCyte, Inc. Method for Preparing Adipose Tissue
ES2968961T3 (es) * 2012-10-18 2024-05-14 Mayo Found Medical Education & Res Técnicas para el tratamiento de abscesos
WO2014186854A1 (pt) * 2013-05-24 2014-11-27 Universidade Estadual De Campinas - Unicamp Processo de obtenção de fio de sutura enriquecido com celulas-tronco, fios obtidos, kit de sutura e seus usos
EP3027235A1 (en) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
EP3581585A1 (en) * 2014-11-26 2019-12-18 Millennium Pharmaceuticals, Inc. Vedolizumab for the treatment of fistulizing crohn's disease
RU2588835C1 (ru) * 2014-11-27 2016-07-10 Олег Германович Макеев Способ терапии повреждений кожи и биотрансплантат для его осуществления
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CA3000912C (en) 2015-10-23 2024-01-09 Rigshospitalet Stem cell therapy based on adipose-derived stem cells
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US11389470B2 (en) * 2016-07-12 2022-07-19 Centre National De La Recherche Scientifique Compositions useful for mucosal healing
IT201700043316A1 (it) * 2017-04-20 2018-10-20 Lipogems Int S P A Drug delivery system
JP6999918B2 (ja) * 2017-08-21 2022-02-04 学校法人慶應義塾 血小板表面抗原と間葉系細胞表面抗原を共発現する血小板様細胞を含む創傷治癒促進剤
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN111840645B (zh) * 2020-07-29 2022-04-01 沈阳细胞治疗工程技术研发中心有限公司 一种瘘洞修补制剂及其制备方法
WO2022139540A1 (ko) * 2020-12-24 2022-06-30 주식회사 로킷헬스케어 조직 재생 패치의 제조방법
CA3228956A1 (en) * 2021-08-12 2023-02-16 Curileum Discovery Ltd Cell populations in the anorectal transition zone with tissue regenerative capacity, and methods for isolation and use thereof
CN114949361A (zh) * 2021-12-31 2022-08-30 浙江金时代生物技术有限公司 一种用于子宫内膜修复的聚乳酸-羟基乙酸共聚物支架与人脐带间充质干细胞复合物的制备方法
EP4704869A2 (en) * 2023-04-28 2026-03-11 Angiocrine Bioscience, Inc. Endothelial cells for treatment of gastrointestinal fistula

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298002A (en) 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5143842A (en) 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5145770A (en) * 1990-06-04 1992-09-08 Biosurface Technology, Inc. Cryopreservation of cultured epithelial sheets
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5624105A (en) 1992-10-10 1997-04-29 Hemscheidt Fahrwerktechnik Gmbh & Co. Hydropneumatic suspension system
DE69317439T2 (de) 1992-12-02 1998-07-02 Shell Int Research Azoxycyanbenzol-Derivate
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5578475A (en) 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
JPH10505250A (ja) * 1994-06-06 1998-05-26 ケース ウエスターン リザーブ ユニバーシティ 組織再生のためのバイオマトリックス
US6174333B1 (en) * 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
CA2222328C (en) 1995-06-07 2012-01-10 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
CA2227584A1 (en) 1995-08-04 1997-02-20 The General Hospital Corporation Transgenic swine and swine cells having human hla genes
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
WO1998031316A1 (en) * 1997-01-17 1998-07-23 Celadon Science, Llc Methods for promoting healing of corneal resurfacing wounds
US6391297B1 (en) 1997-12-02 2002-05-21 Artecel Sciences, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
CA2319448A1 (en) 1998-02-04 1999-08-12 The General Hospital Corporation Costimulatory blockade and mixed chimerism in allotransplantation
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
ES2205792T3 (es) 1998-04-03 2004-05-01 Osiris Therapeutics, Inc. Celulas madre mesenquimatosas como inmunosupresores.
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
IL145002A0 (en) 1999-03-10 2002-06-30 Univ Pittsburgh Adipose-derived stem cells and lattices
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050153442A1 (en) * 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
WO2000073418A2 (en) * 1999-05-28 2000-12-07 Pacgen Technologies Llc A method of using autologous fibroblasts to promote healing of wounds and fistulas
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
JP2003523323A (ja) 1999-12-06 2003-08-05 ザ ジェネラル ホスピタル コーポレーション 膵臓幹細胞および移植におけるその使用
US20020155096A1 (en) 2001-02-23 2002-10-24 Chancellor Michael B. Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
BR0214029A (pt) 2001-11-09 2005-04-19 Artecel Sciences Inc Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas
CA2473727A1 (en) * 2001-12-04 2003-06-12 Christopher J. Woolverton Storage-stable fibrin sealant
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
ES2287447T3 (es) * 2002-02-19 2007-12-16 Medipost, Co., Ltd. Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos.
WO2003105908A2 (en) 2002-03-15 2003-12-24 Department Of Veterans Affairs, Rehabilitation R & D Service Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
WO2003106493A1 (en) * 2002-06-14 2003-12-24 Dyax Corporation Protein analysis
EP1990350A1 (en) 2002-06-14 2008-11-12 Cartela R&D AB Marker for mesenchymal stem cells and its use
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
JP2004190976A (ja) * 2002-12-12 2004-07-08 Sony Corp 熱輸送装置及び電子デバイス
CN1770976A (zh) * 2003-02-13 2006-05-10 人类起源公司 利用脐带血治疗患有疾病、紊乱或状况的个体的用途
EP2263698A1 (en) 2003-04-01 2010-12-22 United States of America Dempartment of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
ES2564044T3 (es) 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
US7645229B2 (en) * 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
WO2005035738A1 (en) * 2003-10-07 2005-04-21 Biomaster Inc. Cell differentiation of adipose-derived precursor cells
DE602004030823D1 (de) 2003-11-04 2011-02-10 Biomaster Inc Verfahren und system zur herstellung von stammzellen aus fettgewebe
WO2005062857A2 (en) 2003-12-24 2005-07-14 The Trustees Of Columbia University In The City Of New York Creation of a biological atrioventricular bypass to compensate for atrioventricular block
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP2298863B1 (en) 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
WO2006029347A2 (en) 2004-09-03 2006-03-16 University Of Maryland, Baltimore Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
CA2623353C (en) 2005-09-23 2017-02-21 Cellerix, S.L. Cell populations having immunoregulatory activity, method for isolation and uses
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20110262402A1 (en) 2007-09-07 2011-10-27 Masahiko Kuroda Therapeutic and prophylactic agents for arthritis
KR101738323B1 (ko) 2007-09-19 2017-05-19 플루리스템 리미티드 지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
ES2595103T3 (es) 2007-10-17 2016-12-27 Txcell Células Tr1, células madre mesenquimales y usos de estas
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
ES2479621T3 (es) 2009-04-28 2014-07-24 Anterogen Co., Ltd. Composición de células madre estromales derivadas de tejido adiposo autólogo y alogénico destinada al tratamiento de fístulas
WO2011004264A1 (en) 2009-07-09 2011-01-13 Cellerix Sa Methods and compositions for use in cellular therapies
WO2012095743A2 (en) 2011-01-12 2012-07-19 Cellerix Sa Methods and compositions for use in intralymphatic cellular therapies
WO2012123401A1 (en) 2011-03-11 2012-09-20 Tigenix, S.A. Cell populations having immunoregulatory activity, method for isolation and uses
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
EP3581932A1 (en) 2013-03-15 2019-12-18 TiGenix, S.A.U. Lymphocyte biomarkers for determining the clinical response to cell therapy
US20160120910A1 (en) 2013-06-25 2016-05-05 Tigenix S.A.U. Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Similar Documents

Publication Publication Date Title
JP2008546397A5 (enExample)
Mafi et al. Adult mesenchymal stem cells and cell surface characterization-a systematic review of the literature
JP2010530214A5 (enExample)
NZ594848A (en) Use of adipose tissue-derived stromal stem cells in treating fistula
SG158853A1 (en) Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue
PH12019500187A1 (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
JP2022027796A5 (enExample)
Coulson-Thomas et al. Extrinsic and intrinsic mechanisms by which mesenchymal stem cells suppress the immune system
HRP20180266T1 (hr) Postupak priprave osnovnog medija za kulturu mezenhimnih matičnih stanica, osnovni medij za kulturu mezenhimnih matičnih stanica, te terapijsko sredstvo za stanice koje se uzgaja i diferencira uz njegovu upotrebu
Guadix et al. Characteristics, applications and prospects of mesenchymal stem cells in cell therapy
JP2016523285A5 (enExample)
JP2017520583A5 (enExample)
HK1201293A1 (en) Adult mesenchymal stem cell (msc) compositions and methods for preparing the same
JP2020533021A5 (enExample)
JP2010518812A5 (enExample)
WO2012040465A3 (en) Multipotent stem cells and uses thereof
JP2010506563A5 (enExample)
CO6251330A2 (es) Tratamiento de enfermedades y transtornos utilizando celulas formadoras de colonias de autorenovacion cultivadas y expandidas in vitro
JP2015523083A5 (enExample)
RU2018133339A (ru) Среда для формирования колоний и её применение
RU2014129756A (ru) Индуцированные плюрипотентные стволовые клетки из клеток, полученных из ткани пуповины человека
Allickson et al. Human adult stem cells from menstrual blood and endometrial tissue
EP2964755B1 (en) Menstrual stems cells for the efficient support and expansion of cd34+ cd133+ hematopoietic stem cells in vitro
RU2015139970A (ru) Популяция стволовых клеток шейки матки человека и ее применение
JP2020519645A5 (enExample)